Sanofi Closes $11.7 Billion Sale of Regeneron Stake
June 01 2020 - 2:12AM
Dow Jones News
By Pietro Lombardi
Sanofi SA has closed the $11.7 billion sale of almost its entire
20.6% stake in U.S. biotech company Regeneron Pharmaceuticals
Inc.
The French pharmaceutical major said it now holds 400,000 shares
in the U.S. company. The sale won't affect the ongoing
collaboration between Sanofi and Regeneron, it said late
Friday.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com
(END) Dow Jones Newswires
June 01, 2020 01:57 ET (05:57 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.